idoxuridine

Modify Date: 2026-07-01 17:30:31

idoxuridine Structure
idoxuridine structure
Common Name idoxuridine
CAS Number 54-42-2 Molecular Weight 354.099
Density 2.1±0.1 g/cm3 Boiling Point N/A
Molecular Formula C9H11IN2O5 Melting Point 194 °C(lit.)
MSDS USA Flash Point N/A
Symbol GHS07 GHS08
GHS07, GHS08
Signal Word Warning

 Use of idoxuridine


Idoxuridine is an antiviral agent for feline herpesvirus type-1 with IC50 of 4.3 μM.Target: herpesvirus type-1Idoxuridine is mainly used topically to treat herpes simplex keratitis. Epithelial lesions, especially initial attacks presenting with a dendritic ulcer, are most responsive to therapy, while infection with stromal involvement are less responsive. Idoxuridine is ineffective against herpes simplex virus type 2 and varicella-zoster.

 Names

This table lists Chinese names, IUPAC names and various aliases of this chemical substance.

Name 5-iodo-2'-deoxyuridine
Synonym More Synonyms

 idoxuridine Biological Activity

This table contains bioactivity, target information and biological‑assay experimental data of this compound.

Description Idoxuridine is an antiviral agent for feline herpesvirus type-1 with IC50 of 4.3 μM.Target: herpesvirus type-1Idoxuridine is mainly used topically to treat herpes simplex keratitis. Epithelial lesions, especially initial attacks presenting with a dendritic ulcer, are most responsive to therapy, while infection with stromal involvement are less responsive. Idoxuridine is ineffective against herpes simplex virus type 2 and varicella-zoster.
Related Catalog
References

[1]. Seth AK, et al. Topical liposomal gel of idoxuridine for the treatment of herpes simplex: pharmaceutical and clinical implications.Pharm Dev Technol. 2004 Aug;9(3):277-89.

[2]. Fauth E, et al. Comparison of spontaneous and idoxuridine-induced micronuclei by chromosome painting. Mutat Res. 1999 Apr 6;440(2):147-56.

[3]. Otto SE. Radiopharmaceuticals (Strontium 89) and radiosensitizers (idoxuridine). J Intraven Nurs. 1998 Nov-Dec;21(6):335-7.

 Chemical & Physical Properties

This table shows physicochemical parameters including melting point, boiling point, density, solubility and optical rotation. Missing data is marked as N/A.

Density 2.1±0.1 g/cm3
Melting Point 194 °C(lit.)
Molecular Formula C9H11IN2O5
Molecular Weight 354.099
Exact Mass 353.971252
PSA 104.55000
LogP -0.52
Index of Refraction 1.715
InChIKey XQFRJNBWHJMXHO-RRKCRQDMSA-N
SMILES O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1I
Water Solubility 1.6 g/L (20 ºC)

 MSDS

This table provides MSDS information including hazard classification, first‑aid, fire‑fighting, spill handling, operation and storage instructions.

 Toxicological Information

This table summarizes toxicological test data, acute & chronic toxicity and ecological hazard parameters for this chemical.

CHEMICAL IDENTIFICATION

RTECS NUMBER :
YU7700000
CHEMICAL NAME :
Uridine, 2'-deoxy-5-iodo-
CAS REGISTRY NUMBER :
54-42-2
BEILSTEIN REFERENCE NO. :
0030397
LAST UPDATED :
199806
DATA ITEMS CITED :
37
MOLECULAR FORMULA :
C9-H11-I-N2-O5
MOLECULAR WEIGHT :
354.12
WISWESSER LINE NOTATION :
T6NVMVJ EI A- ET5OTJ B1Q CQ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
4 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>10 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
4589 mg/kg/18D-I
TOXIC EFFECTS :
Nutritional and Gross Metabolic - weight loss or decreased weight gain Related to Chronic Data - death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
100 mg/kg/8W-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Blood - leukemia
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
100 mg/kg
SEX/DURATION :
female 7 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
300 mg/kg
SEX/DURATION :
female 7 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
300 mg/kg
SEX/DURATION :
female 10 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue) Reproductive - Specific Developmental Abnormalities - musculoskeletal system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
600 mg/kg
SEX/DURATION :
female 16-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - stillbirth
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Unreported
DOSE :
300 mg/kg
SEX/DURATION :
female 10 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Ocular
DOSE :
1350 mg/kg
SEX/DURATION :
female 6-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death Reproductive - Specific Developmental Abnormalities - eye/ear Reproductive - Specific Developmental Abnormalities - musculoskeletal system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Ocular
DOSE :
3250 ug/kg
SEX/DURATION :
female 6-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death Reproductive - Specific Developmental Abnormalities - eye/ear Reproductive - Specific Developmental Abnormalities - musculoskeletal system
TYPE OF TEST :
Specific locus test
TYPE OF TEST :
Sister chromatid exchange
TYPE OF TEST :
Cytogenetic analysis
TYPE OF TEST :
Sperm Morphology

MUTATION DATA

TYPE OF TEST :
DNA inhibition
TEST SYSTEM :
Rodent - rabbit Kidney
DOSE/DURATION :
1 mg/L
REFERENCE :
JMCMAR Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- Volume(issue)/page/year: 24,390,1981 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X5053 No. of Facilities: 21 (estimated) No. of Industries: 1 No. of Occupations: 2 No. of Employees: 618 (estimated) No. of Female Employees: 318 (estimated)

 Safety Information

This table covers safety warnings, protective measures, incompatible substances and disposal guidelines for this compound.

Symbol GHS07 GHS08
GHS07, GHS08
Signal Word Warning
Hazard Statements H315-H319-H335-H341-H361
Precautionary Statements P280-P305 + P351 + P338
Personal Protective Equipment Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges
Hazard Codes T:Toxic
Risk Phrases R45;R46;R61
Safety Phrases S53-S45
RIDADR NONH for all modes of transport
WGK Germany 3
RTECS YU7700000
HS Code 2934999090

 Synthetic Route

This table presents publicly reported synthetic routes, reaction conditions, reactants and product information of the compound.

~%

idoxuridine Structure

idoxuridine

CAS#:54-42-2

Learn More
Literature: Journal of Molecular Catalysis B: Enzymatic, , vol. 95, p. 16 - 22

~96%

idoxuridine Structure

idoxuridine

CAS#:54-42-2

Learn More
Literature: Kumar; Wiebe; Knaus Canadian Journal of Chemistry, 1994 , vol. 72, # 9 p. 2005 - 2010

~92%

idoxuridine Structure

idoxuridine

CAS#:54-42-2

Learn More
Literature: Asakura, Jun-ichi; Robins, Morris J. Journal of Organic Chemistry, 1990 , vol. 55, # 16 p. 4928 - 4933

~%

idoxuridine Structure

idoxuridine

CAS#:54-42-2

Learn More
Literature: US4851520 A1, ;

~90%

idoxuridine Structure

idoxuridine

CAS#:54-42-2

Learn More
Literature: Hatano, Akihiko; Harano, Aiko; Kirihara, Masayuki Chemistry Letters, 2006 , vol. 35, # 2 p. 232 - 233

~%

idoxuridine Structure

idoxuridine

CAS#:54-42-2

Learn More
Literature: Journal of Organic Chemistry, , vol. 55, # 16 p. 4928 - 4933

~%

idoxuridine Structure

idoxuridine

CAS#:54-42-2

Learn More
Literature: Journal of Labelled Compounds and Radiopharmaceuticals, , vol. 34, # 6 p. 513 - 522

~%

idoxuridine Structure

idoxuridine

CAS#:54-42-2

Learn More
Literature: Collection of Czechoslovak Chemical Communications, , vol. 59, # 10 p. 2303 - 2330

 Customs

This table shows customs‑related data including HS‑code, tariff and regulatory conditions for import and export.

HS Code 2934999090
Summary 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

 Articles54

More Articles

This table lists relevant public references with title, journal and publication metadata for this compound.

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

J. Sci. Ind. Res. 65(10) , 808, (2006)

Drug-induced liver injury (DILI) is a significant concern in drug development due to the poor concordance between preclinical and clinical findings of liver toxicity. We hypothesized that the DILI typ...

Developing structure-activity relationships for the prediction of hepatotoxicity.

Chem. Res. Toxicol. 23 , 1215-22, (2010)

Drug-induced liver injury is a major issue of concern and has led to the withdrawal of a significant number of marketed drugs. An understanding of structure-activity relationships (SARs) of chemicals ...

A predictive ligand-based Bayesian model for human drug-induced liver injury.

Drug Metab. Dispos. 38 , 2302-8, (2010)

Drug-induced liver injury (DILI) is one of the most important reasons for drug development failure at both preapproval and postapproval stages. There has been increased interest in developing predicti...

 Synonyms

This table collects all English aliases, systematic names and CAS‑related synonyms of the compound.

5-Iodo-2'-desoxyuridine
UNII-LGP81V5245
Dendrid (Trade name)
5-Iodo-2'-Deoxyuridine
Idoxene
Idulea
1-[(2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-5-iodo-2,4(1H,3H)-pyrimidinedione
idoxuridine
STOXIL
Ophthalmadine
HERPLEX
EINECS 200-207-8
1-(2-Deoxy-β-D-erythro-pentofuranosyl)-5-iodpyrimidin-2,4(1H,3H)-dion
Kerecid
2′-Deoxy-5-iodouridine
2'-Deoxy-5-iodouridine
Virudox
5-Iodo-2′-deoxyuridine
MFCD00134656
Iduridin

 idoxuridine | FAQ

This section contains frequently‑asked‑questions about this compound, including basic parameters, properties, storage conditions and corresponding answers.

Q: What is the English name of 5-iodo-2'-deoxyuridine?
A: The English name of 5-iodo-2'-deoxyuridine is 5-iodo-2'-deoxyuridine.
Q: What English synonyms does 5-iodo-2'-deoxyuridine have?
A: English synonyms of 5-iodo-2'-deoxyuridine: 5-Iodo-2'-desoxyuridine, UNII-LGP81V5245, Dendrid (Trade name), 5-Iodo-2'-Deoxyuridine, Idoxene, Idulea, 1-[(2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-5-iodo-2,4(1H,3H)-pyrimidinedione, idoxuridine, STOXIL, Ophthalmadine, HERPLEX, EINECS 200-207-8, 1-(2-Deoxy-β-D-erythro-pentofuranosyl)-5-iodpyrimidin-2,4(1H,3H)-dion, Kerecid, 2′-Deoxy-5-iodouridine, 2'-Deoxy-5-iodouridine, Virudox, 5-Iodo-2′-deoxyuridine, MFCD00134656, Iduridin.
Q: What is the polar surface area (PSA) of 5-iodo-2'-deoxyuridine?
A: Polar surface area (PSA) of 5-iodo-2'-deoxyuridine is 104.55000.
Q: How is the water solubility of 5-iodo-2'-deoxyuridine?
A: Water solubility of 5-iodo-2'-deoxyuridine: 1.6 g/L (20 ºC).
Q: What are the uses of 5-iodo-2'-deoxyuridine?
A: Main uses of 5-iodo-2'-deoxyuridine: Idoxuridine is an antiviral agent for feline herpesvirus type-1 with IC50 of 4.3 μM.Target: herpesvirus type-1Idoxuridine is mainly used topically to treat herpes simplex keratitis. Epithelial lesions, especially initial attacks presenting with a dendritic ulcer, are most responsive to therapy, while infection with stromal involvement are less responsive. Idoxuridine is ineffective against herpes simplex virus type 2 and varicella-zoster.
Q: What is the LogP of 5-iodo-2'-deoxyuridine?
A: LogP of 5-iodo-2'-deoxyuridine is -0.52.
Q: What are the downstream products of 5-iodo-2'-deoxyuridine?
A: Related downstream products(CAS) of 5-iodo-2'-deoxyuridine: 951-78-0;50-90-8;144989-71-9;92233-50-6;37972-24-0;1956-30-5;215668-76-1;36792-88-8;696-07-1;66-22-8.
Q: What is the InChIKey of 5-iodo-2'-deoxyuridine?
A: InChIKey of 5-iodo-2'-deoxyuridine is XQFRJNBWHJMXHO-RRKCRQDMSA-N.
Q: What is the CAS number of 5-iodo-2'-deoxyuridine?
A: CAS number of 5-iodo-2'-deoxyuridine is 54-42-2.
Q: What are the upstream materials of 5-iodo-2'-deoxyuridine?
A: Related upstream materials(CAS) of 5-iodo-2'-deoxyuridine: 951-78-0;696-07-1;1956-30-5;65505-76-2;51592-06-4;50-89-5;13030-62-1;146629-34-7.

 idoxuridinefactory

This table lists manufacturers and suppliers of this compound, including vendor names and product supply reference information.

Shanghai Nianxing Industrial Co., Ltd
Dayang Chem (Hangzhou) Co., Ltd.
Henan Tianfu Chemical Co., Ltd.
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here



Get all suppliers and price by the below link:

idoxuridine suppliers


Price: ¥53.6/1g

Reference only. check more idoxuridine price